Ildong Holdings Acquires Additional 15 Billion KRW Worth of Shares in Subsidiary Idions

[Asia Economy Reporter Lim Chunhan] Ildong Holdings announced on the 21st that it will additionally acquire 2,238,058 shares of its pharmaceutical clinical, intellectual property management, and licensing subsidiary, Ideance, for approximately 15 billion KRW.